ENTRY       D00824                      Drug
NAME        Fluvoxamine maleate (JP18/USP);
            Luvox (TN)
PRODUCT
  GENERIC   FLUVOXAMINE MALEATE (A-S Medication Solutions)
            FLUVOXAMINE MALEATE (ANI Pharmaceuticals)
            FLUVOXAMINE MALEATE (Actavis Pharma)
            FLUVOXAMINE MALEATE (Apotex Corp)
            FLUVOXAMINE MALEATE (Bionpharma)
            FLUVOXAMINE MALEATE (Bryant Ranch Prepack)
            FLUVOXAMINE MALEATE (Bryant Ranch Prepack)
            FLUVOXAMINE MALEATE (Bryant Ranch Prepack)
            FLUVOXAMINE MALEATE (Bryant Ranch Prepack)
            FLUVOXAMINE MALEATE (PD-Rx Pharmaceuticals)
            FLUVOXAMINE MALEATE (Par Pharmaceutical)
            FLUVOXAMINE MALEATE (Preferred Pharmaceuticals)
            FLUVOXAMINE MALEATE (Preferred Pharmaceuticals)
            FLUVOXAMINE MALEATE (REMEDYREPACK)
            FLUVOXAMINE MALEATE (REMEDYREPACK)
            FLUVOXAMINE MALEATE (REMEDYREPACK)
            FLUVOXAMINE MALEATE (REMEDYREPACK)
            FLUVOXAMINE MALEATE (Upsher-Smith Laboratories)
FORMULA     C15H21F3N2O2. C4H4O4
EXACT_MASS  434.1665
MOL_WEIGHT  434.4068
CLASS       Neuropsychiatric agent
             DG01659  Selective serotonin reuptake inhibitor (SSRI)
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
            Metabolizing enzyme inhibitor
             DG01634  CYP1A2 inhibitor
             DG01643  CYP2C9 inhibitor
             DG01933  CYP2C19 inhibitor
             DG01645  CYP2D6 inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
              DG01522  CYP3A4 inhibitor
REMARK      Therapeutic category: 1179
            ATC code: N06AB08
            Chemical structure group: DG00946
            Product (DG00946): D00824<JP/US>
EFFICACY    Antidepressant, Selective serotonin reuptake inhibitor (SSRI)
  DISEASE   Obsessive compulsive disorder [DS:H01450]
TARGET      SLC6A4 (HTT) [HSA:6532] [KO:K05037]
  PATHWAY   hsa04726(6532)  Serotonergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION CYP inhibition: CYP1A2 [HSA:1544], CYP2C19 [HSA:1557]; CYP2C9 [HSA:1559], CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]
STR_MAP     map07027  Antidepressants
            map07234  Neurotransmitter transporter inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AB Selective serotonin reuptake inhibitors
                 N06AB08 Fluvoxamine
                  D00824  Fluvoxamine maleate (JP18/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antidepressants
              SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
               Fluvoxamine
                D00824  Fluvoxamine maleate (JP18/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               117  Psychotropics
                1179  Others
                 D00824  Fluvoxamine maleate (JP18/USP)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01659  Selective serotonin reuptake inhibitor (SSRI)
               DG00946  Fluvoxamine
                D00824  Fluvoxamine maleate
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00946  Fluvoxamine
                D00824  Fluvoxamine maleate
             Metabolizing enzyme inhibitor
              DG01634  CYP1A2 inhibitor
               DG00946  Fluvoxamine
                D00824  Fluvoxamine maleate
              DG01643  CYP2C9 inhibitor
               DG00946  Fluvoxamine
                D00824  Fluvoxamine maleate
              DG01933  CYP2C19 inhibitor
               DG00946  Fluvoxamine
                D00824  Fluvoxamine maleate
              DG01645  CYP2D6 inhibitor
               DG00946  Fluvoxamine
                D00824  Fluvoxamine maleate
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                DG00946  Fluvoxamine
                 D00824  Fluvoxamine maleate
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG01659  Selective serotonin reuptake inhibitor (SSRI)
               D00824  Fluvoxamine maleate
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC6
                SLC6A4 (HTT)
                 D00824  Fluvoxamine maleate (JP18/USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00824  Fluvoxamine maleate
              D00824  Fluvoxamine maleate tablets
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00824
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00824
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01659  Selective serotonin reuptake inhibitor (SSRI)
               DG00946  Fluvoxamine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00946  Fluvoxamine
             Metabolizing enzyme inhibitor
              DG01634  CYP1A2 inhibitor
               DG00946  Fluvoxamine
              DG01643  CYP2C9 inhibitor
               DG00946  Fluvoxamine
              DG01933  CYP2C19 inhibitor
               DG00946  Fluvoxamine
              DG01645  CYP2D6 inhibitor
               DG00946  Fluvoxamine
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                DG00946  Fluvoxamine
DBLINKS     CAS: 61718-82-9
            PubChem: 7847889
            ChEBI: 5139
            LigandBox: D00824
            NIKKAJI: J529.785K
ATOM        30
            1   C2b C    39.7600  -15.4000
            2   C2b C    41.4400  -15.4000
            3   C6a C    39.0600  -16.5900
            4   C6a C    42.1400  -16.5900
            5   O6a O    37.6600  -16.5900
            6   O6a O    39.7600  -17.7800
            7   O6a O    41.4400  -17.7800
            8   O6a O    43.5400  -16.5900
            9   C8y C    23.5900  -14.4900
            10  C8x C    23.5900  -15.8900
            11  C8x C    24.7800  -16.5900
            12  C8y C    26.0400  -15.8900
            13  C8x C    26.0400  -14.4900
            14  C8x C    24.7800  -13.7900
            15  C1d C    22.4000  -13.7900
            16  X   F    21.1400  -13.0900
            17  X   F    23.0300  -12.5300
            18  X   F    21.7700  -15.0500
            19  C2c C    27.2300  -16.5900
            20  C1b C    28.4900  -15.8900
            21  N2b N    27.2300  -17.9900
            22  O2a O    28.4900  -18.6900
            23  C1b C    29.6800  -17.9900
            24  C1b C    30.8700  -18.6900
            25  N1a N    32.0600  -17.9900
            26  C1b C    29.6100  -16.5900
            27  C1b C    30.8700  -15.8900
            28  C1b C    32.0600  -16.5900
            29  O2a O    33.2500  -15.8900
            30  C1a C    34.4400  -16.5900
BOND        29
            1     1   2 2
            2     1   3 1
            3     2   4 1
            4     3   5 1
            5     3   6 2
            6     4   7 1
            7     4   8 2
            8     9  10 2
            9    10  11 1
            10   11  12 2
            11   12  13 1
            12   13  14 2
            13    9  14 1
            14    9  15 1
            15   15  16 1
            16   15  17 1
            17   15  18 1
            18   12  19 1
            19   19  20 1
            20   19  21 2
            21   21  22 1
            22   22  23 1
            23   23  24 1
            24   24  25 1
            25   20  26 1
            26   26  27 1
            27   27  28 1
            28   28  29 1
            29   29  30 1
///
